Nyxoah pulls in funding

Nyxoah S.A., which specializes in treating sleep apnea, has raised 25 million euros in financing.

Iris Dorbian

18 February 2020

Nyxoah S.A., which specializes in treating sleep apnea, has raised 25 million euros in financing. ResMed Inc joined as a new shareholder.

Register now

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Not for publication, email or dissemination